Navigation Links
Xention Reports Positive Phase 1 Data for New Atrial Fibrillation Drug
Date:3/20/2012

gs, many of which have significant side effects. The potential market for XEN-D0103 is significant with one in four adults over the age of 40 developing AF in their lifetimes and approximately three million patients suffering atrial-fibrillation-related strokes each year. We are now preparing for the initiation of phase 2 efficacy trial of XEN-D0103 in patients with atrial fibrillation".

XEN-D0103 is the lead product of Xention's portfolio of atrial fibrillation drugs. In addition to targeting Kv1.5, Xention is also conducting research on inhibition of the acetylcholine-activated potassium channel IKACh (Kir3.1/3.4) and highly potent and selective IKACh antagonists are currently under evaluation in preclinical models. The ion channels Kv1.5 and IKACh represent two of the most exciting targets for novel atrial fibrillation therapies, and Xention is at the forefront in developing effective drug modulators of these channels.

About Atrial Fibrillation:

Atrial Fibrillation (AF) is the most common sustained cardiac rhythm disturbance, occurring in between 1 and 2 per cent of the general population but increasing rapidly with age.  It is estimated that over six million Europeans suffer from this arrhythmia and its prevalence is calculated to increase by at least 2.5 fold in the next 50 years as the population ages.  AF confers a five-fold increased risk of stroke and one in five of all strokes are attributable to AF.  The ischemic strokes seen in association with the arrhythmia are often fatal, and those that survive are often left crippled by their stroke and likely to suffer recurrent strokes.  Around one per cent of the healthcare budget of Western European and North American countries is spent on the management of AF.  Thus this disease presents a rapidly growing social, medical and public health problem in need of urgent solution.

Notes to Editors

About Xention:

Xention Ltd is a leading d
'/>"/>

SOURCE Xention
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. GenVec Reports Fourth Quarter and 2011 Year-End Financial Results
2. EntreMed Reports Fourth Quarter and Year-End 2011 Financial Results
3. Phalanx Biotech Group Reports Robust Revenue Growth in 2011
4. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2011 Financial Results
5. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
6. Gen-Probe Reports Financial Results for the Fourth Quarter of 2011
7. Neuland Labs Reports Third Quarter Fiscal Year 2012 Financial Results
8. Cepheid Reports Fourth Quarter and Full Year 2011 Results
9. Covance Reports Fourth Quarter Revenue of $532M, GAAP EPS of $0.35, Pro Forma EPS of $0.73, and Adjusted Net Orders of $759M
10. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
11. Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Three Lawrence Livermore ... Hydrogen Production R&D Award for their ... water using sunlight. , Shared with collaborators from ... University of Nevada, Las Vegas (UNLV), the award ... of photoelectrochemical solar-hydrogen production and corrosion processes. , ...
(Date:8/29/2014)... Due to a misstatement posted by the Family ... Technology Center, LLC ( ASCTC ) was reported as an ... might benefit ALS patients. Because of ASCTC's exclusive focus ... and therapeutic applications, FRC listed ASCTC as one of several ... wish not to support research that requires the death of ...
(Date:8/29/2014)... A major challenge before new biotechnology start-up companies, ... Boston-Cambridge, is gaining visibility that can lead to important ... of Boston’s Adult Stem Cell Technology Center, LLC (ASCTC), ... his company an important priority since he started the ... social media marketing campaign launched earlier in ...
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
Breaking Biology Technology:Livermore Team Awarded for Hydrogen Production Research 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 2The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 3The Adult Stem Cell Technology Center, LLC Participates in Multiple Stem Cell and Regenerative Medicine Conferences Before Year End 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... the SciVerse ScienceDirect eBooks Collection 2011 Frontlist -- ST. LOUIS, November 15, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... N.C., Nov. 15, 2010 Talecris Biotherapeutics (Nasdaq: ... data from two studies demonstrating that augmentation therapy with ... in patients with emphysema related to Alpha(1)-antitrypsin (AAT) deficiency. ... of the raw data from two similar pilot trials, ...
... ... ... var shortURL = ""; BitlyCB.alertResponse = ... the first one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) ...
Cached Biology Technology:Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 2Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 3Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 4Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 5Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 6Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 7Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 8Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 9Elsevier Announces the SciVerse ScienceDirect eBooks Collection 2011 Frontlist 10Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 2Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 3Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 4Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema 5MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 2MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 3MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 4MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 5MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 6MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 7MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 8MEDICAGO ANNOUNCES 2010 THIRD QUARTER FINANCIAL RESULTS 9
(Date:8/28/2014)... Invasives is now available from the Lady Bird Johnson ... for identifying harmful non-native plant, insect and other invasive ... States cause about $137 billion in economic and other ... kill native plants and more. , "By having streamlined ... invasive species occur, we,re more likely to catch these ...
(Date:8/28/2014)... pleased to announce the selection of Dr. Fred Baxendale ... acknowledges those who have served ESA for at least ... the Society that has reached an extraordinary level. Candidates ... Board and then voted on by the ESA membership. ... at Entomology 2014, ESA,s Annual Meeting in Portland, Oregon ...
(Date:8/28/2014)... bacterial culprits that may drive inflammatory bowel diseases (IBD) ... own intestinal immune responses as a guide. , The ... Cell . , Trillions of bacteria exist within the ... the development and progression of IBD. Yet it,s thought ... a person,s susceptibility to IBD and its potential severity. ...
Breaking Biology News(10 mins):Mobile app makes ID of harmful plants, insects in Texas a snap 2Fred Baxendale selected as Honorary Member of the Entomological Society of America 2Yale study identifies possible bacterial drivers of IBD 2
... gene transcription the process inside the nucleus of cells ... molecules a large, ever-changing multiprotein complex is enlisted to ... Like an exquisitely choreographed dance, each step in the process ... copy to be accurate and useful in subsequent events. ...
... Among the 75 people Esquire magazine recently ... are three researchers in an emerging discipline that combines ... novel biological functions and systems otherwise known as ... scientific field lies in the potential to apply engineering ...
... "Life happens at the level of proteins . ... polymerize, repair, support, modify, degrade, fold, migrate, and transport; ... carry, and repress; they bind, transfer, translocate, amplify, proofread, ... is from the preface of the new book ...
Cached Biology News:CSHL scientists discover new way in which ubiquitin modifies transcriptional machinery 2New manual presents robust, state-of-the-art proteomics methods for teaching and research 2
... your microarray data using Asuragens bioinformatics expertise. ... consultation to extensive data analysis using the ... expertise in combination with the Gene Expression ... experiments., ,Normalization and basic statistical analysis including ...
BD Falcon 850 cm Smooth-surface TufRol Roller Bottle, tissue-culture treated polystyrene, blow-molded one-piece design, with easy on/off non-vented cap. (2/sp, 20/ca) Packaging: 2 / pack, 20 /...
... Time of Flight Mass Analyzer for superior sensitivity, mass accuracy, and ... 25,000 m/z, * Precursor ion selection range: 150 - 4000 m/z, ... ppm with internal reference, * Dynamic range: 4 orders of magnitude ... ...
Four siRNAs targeting your gene of interest, providing gene silencing with 100% satisfaction guaranteed High knockdown potency , High specificity for minimal off-target effects , Flexible siR...
Biology Products: